Dr. Moira Gunn talks to JJ Bienaime, President & CEO of BioMarin Pharmaceuticals about the problem of orphan diseases, diseases not yet under research by pharmaceutical companies because of a lack of financial incentive to market new medications for treatment.
Tech Nation w/Moira Gunn
